ADAG
Price:
$3.94
Market Cap:
$148.34M
Adagene Inc. functions as a clinical-stage biopharmaceutical organization, primarily concentrating on the identification, evolution, and fabrication of monoclonal antibody-based therapeutics engineered to combat various types of cancer. The company's developmental pipeline encompasses several investigational assets currently undergoing human trials. Among these is ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibody, which is navigating Phase 1b/2 clinical assessment for individuals with advanced solid tumors and non-Hodgkin's lymphoma. Additionally, Adagene is progressing ADG126, a fully-human anti-CTLA-4 mAb, and ADG116, another human ligand-blocking anti-CTLA-4 mAb, bo...[Read more]
Industry
Biotechnology
IPO Date
2021-02-09
Stock Exchange
NASDAQ
Ticker
ADAG
According to Adagene Inc.’s latest financial reports and current stock price. The company's current ROE is -48.20%. This represents a change of 72.57% compared to the average of -27.93% of the last 4 quarters.
The mean historical ROE of Adagene Inc. over the last ten years is -25.15%. The current -48.20% ROE has changed 91.62% with respect to the historical average. Over the past ten years (40 quarters), ADAG's ROE was at its highest in in the December 2019 quarter at 9.05%. The ROE was at its lowest in in the December 2024 quarter at -49.32%.
Average
-25.15%
Median
-36.80%
Minimum
-96.25%
Maximum
35.88%
Discovering the peaks and valleys of Adagene Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 146.37%
Maximum Annual ROE = 35.88%
Minimum Annual Increase = -354.22%
Minimum Annual ROE = -96.25%
| Year | ROE | Change |
|---|---|---|
| 2025 | -49.82% | -24.70% |
| 2024 | -66.16% | 146.37% |
| 2023 | -26.85% | -72.10% |
| 2022 | -96.25% | 105.91% |
| 2021 | -46.74% | -354.22% |
| 2020 | 18.39% | -39.39% |
| 2019 | 30.34% | -15.45% |
The current ROE of Adagene Inc. (ADAG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-47.61%
5-year avg
-57.16%
10-year avg
-25.15%
Adagene Inc.’s ROE is greater than XBiotech Inc. (-26.10%), greater than CervoMed Inc. (-136.08%), greater than Gain Therapeutics, Inc. (-201.43%), greater than Nutriband Inc. (-112.60%), greater than Adicet Bio, Inc. (-80.35%), less than Fortress Biotech, Inc. (163.88%), greater than Lite Strategy, Inc. (-90.81%), greater than TScan Therapeutics, Inc. (-91.94%), less than OS Therapies Incorporated (3.21%), less than NRx Pharmaceuticals, Inc. (107.73%),
| Company | ROE | Market cap |
|---|---|---|
| -26.10% | $70.43M | |
| -136.08% | $39.26M | |
| -201.43% | $80.19M | |
| -112.60% | $35.25M | |
| -80.35% | $75.72M | |
| 163.88% | $99.33M | |
| -90.81% | $28.17M | |
| -91.94% | $56.19M | |
| 3.21% | $85.96M | |
| 107.73% | $68.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adagene Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Adagene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Adagene Inc.'s ROE?
How is the ROE calculated for Adagene Inc. (ADAG)?
What is the highest ROE for Adagene Inc. (ADAG)?
What is the 3-year average ROE for Adagene Inc. (ADAG)?
What is the 5-year average ROE for Adagene Inc. (ADAG)?
How does the current ROE for Adagene Inc. (ADAG) compare to its historical average?